PRMT5 and neoplasm: To rule out the possibility that reduced metastasis was conveyed by insufficient primary tumor growth, we tested SK-N-BE(2) neuroblastoma cells expressing iRFP720 and doxycycline-inducible PRMT5 shRNA in a metastatic mouse model.